@Boffin99
In theory, OK?
RAC is an investment opportunity that investors should want to buy based on the strategic direction Race Oncology Ltd have planned, documented, staffed for, and (be funded to) execute.
Therefore the more that shareholders feel like they need to contribute to the strategic direction of the company - the bigger the issue.
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-125
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.060(4.00%) |
Mkt cap ! $245.4M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.44 | $57.11K | 38.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2499 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 247 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |